Official: US to spend $3B for antiviral pills for COVID-19

By: |
June 17, 2021 9:18 PM

The pills, which would be used to minimize symptoms after infection, are in development and could begin arriving by year’s end, pending the completion of clinical trials.

Guleria has said the third could be just six-eight weeks away if Covid-appropriate behaviour is not followed.Guleria has said the third could be just six-eight weeks away if Covid-appropriate behaviour is not followed.

The United States is devoting more than $3 billion to advance development of antiviral pills for COVID-19, according to an official briefed on the matter.

The pills, which would be used to minimize symptoms after infection, are in development and could begin arriving by year’s end, pending the completion of clinical trials.

The White House is scheduled to hold a briefing on its COVID-19 plans with Dr. Anthony Fauci, the nation’s top infectious disease expert.

News of the administration’s plans for the pill was first reported Thursday by The New York Times. The official who confirmed the report spoke on the condition of anonymity ahead of an announcement.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Coronavirus did leak from China’s Wuhan Institute of Virology, claims explosive report by US Republicans
2Department of physiotherapy at DPSRU launches pediatrics physiotherapy unit
3Over 3.14 crore Covid vaccine doses available with states, UTs and pvt hospitals: Govt